Université de St-Gall - Schools of Management

The MNC as an externally embedded organization: An investigation of embeddedness overlap in local subsidiary networks

Description: 

MNCs have been conceptualized as differentiated networks that, in turn, are embedded in external networks. Previous research has predominantly focused on the embeddedness of established subsidiaries into their local environment, omitting to shed light on the phenomenon of headquarters linkages to the local context which creates embeddedness overlap. We develop a model of why MNCs develop overlapping linkages to local subsidiary networks even if the subsidiaries have grown out of the initial start-up phase. Using detailed information on 168 European subsidiaries, we find that MNCs build and maintain more overlapping network ties when subsidiaries are high performers, hold important resources, operate in turbulent environments, and are closely connected to multinational actors as opposed to purely domestic firms.

Pfizer and the Challenges of the Global Pharmaceutical Industry

Parenting Advantage in the MNC : An Embeddedness Perspective on the Value Added by Headuarters

Description: 

What determines the value an MNC's headquarters adds to its own affiliates? In this paper, we shed light on this question by linking the embeddedness view of the multinational corporation to the literature on parenting advantage. We test our hypotheses on an original dataset of 124 manufacturing subsidiaries located in Europe. Our results indicate that the external embeddedness of the MNC is an antecedent to headquarters' value creation. We find that headquarters' investments into their own relationships with the subsidiaries' contexts are positively related to the value added by headquarters. Furthermore, this relationship is stronger when the subsidiary itself is strongly embedded. We discuss implications for the MNC literature, embeddedness research, and the literature on parenting and headquarters' roles.

Fallstudienlösung "Pfizer und die globale Pharmaindustrie"

Pfizer und die Globale Pharmaindustrie

Integration von Unternehmensakquisitionen in den neuen Bundesländern - Teil 1. Die Probleme werden oft bewusst abgewiegelt

Integration von Akquisitionen in den neuen Bundesländern - Teil 3. Häufig kam es zu einer dramatischen Fehleinschätzung der laufenden Kosten

Integration von Akquisitionen in den neuen Bundesländern - Teil 2. Die Erwartungen müssen meist deutlich nach unten revidiert werden

The management of contradictions - A new challenge for leadership

Mergers & Acquisitions : Markttendenzen und Beraterprofile

Pagine

Le portail de l'information économique suisse

© 2016 Infonet Economy

Abbonamento a RSS - Université de St-Gall - Schools of Management